These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30370347)

  • 1. Generating antitumor immunity by targeted radiation therapy: Role of dose and fractionation.
    Ko EC; Benjamin KT; Formenti SC
    Adv Radiat Oncol; 2018; 3(4):486-493. PubMed ID: 30370347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Awakening the immune system with radiation: Optimal dose and fractionation.
    Gandhi SJ; Minn AJ; Vonderheide RH; Wherry EJ; Hahn SM; Maity A
    Cancer Lett; 2015 Nov; 368(2):185-90. PubMed ID: 25799953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single High-Dose Irradiation-Induced iRhom2 Upregulation Promotes Macrophage Antitumor Activity Through cGAS/STING Signaling.
    Zhao X; Wang B; Zhuang Y; Du S; Zeng Z
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1150-1162. PubMed ID: 36792017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T Cells Shape the Differential Impact of Radiation Dose-Fractionation Schedules on Host Innate and Adaptive Antitumor Immune Defenses.
    Sia J; Hagekyriakou J; Chindris I; Albarakati H; Leong T; Schlenker R; Keam SP; Williams SG; Neeson PJ; Johnstone RW; Haynes NM
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):502-514. PubMed ID: 34023423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade.
    Moore C; Hsu CC; Chen WM; Chen BPC; Han C; Story M; Aguilera T; Pop LM; Hannan R; Fu YX; Saha D; Timmerman R
    Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1306-1316. PubMed ID: 33794306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation as an immunological adjuvant: current evidence on dose and fractionation.
    Demaria S; Formenti SC
    Front Oncol; 2012; 2():153. PubMed ID: 23112958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
    Demaria S; Guha C; Schoenfeld J; Morris Z; Monjazeb A; Sikora A; Crittenden M; Shiao S; Khleif S; Gupta S; Formenti SC; Vikram B; Coleman CN; Ahmed MM
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33827904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies.
    Boustani J; Lecoester B; Baude J; Latour C; Adotevi O; Mirjolet C; Truc G
    Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation Dose Escalation is Crucial in Anti-CTLA-4 Antibody Therapy to Enhance Local and Distant Antitumor Effect in Murine Osteosarcoma.
    Takenaka W; Takahashi Y; Tamari K; Minami K; Katsuki S; Seo Y; Isohashi F; Koizumi M; Ogawa K
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation.
    Buchwald ZS; Wynne J; Nasti TH; Zhu S; Mourad WF; Yan W; Gupta S; Khleif SN; Khan MK
    Front Oncol; 2018; 8():612. PubMed ID: 30619752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of radiation in the context of developing combination immunotherapies in cancer.
    Honeychurch J; Illidge TM
    Ther Adv Vaccines Immunother; 2017 Dec; 5(6):115-122. PubMed ID: 29998216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiobiology of hypofractionated stereotactic radiotherapy: what are the optimal fractionation schedules?
    Shibamoto Y; Miyakawa A; Otsuka S; Iwata H
    J Radiat Res; 2016 Aug; 57 Suppl 1(Suppl 1):i76-i82. PubMed ID: 27006380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Radiation on the Tumor Microenvironment: Effect of Dose and Fractionation Schedules.
    Arnold KM; Flynn NJ; Raben A; Romak L; Yu Y; Dicker AP; Mourtada F; Sims-Mourtada J
    Cancer Growth Metastasis; 2018; 11():1179064418761639. PubMed ID: 29551910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal Radiation Therapy Fractionation Regimens for Early-Stage Non-Small Cell Lung Cancer.
    Liu F; Ververs JD; Farris MK; Blackstock AW; Munley MT
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):829-838. PubMed ID: 37734445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of anti-PDL-1 with ablative radiation comparing to other regimens with same biological effect dose based on different immunogenic response.
    Alinezhad M; Bakhshandeh M; Rostami E; Alimohamadi R; Mosaffa N; Jalali SA
    PLoS One; 2020; 15(4):e0231507. PubMed ID: 32287292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Whole Brain Radiation Therapy in Adults With Newly Diagnosed Metastatic Brain Tumors.
    Gaspar LE; Prabhu RS; Hdeib A; McCracken DJ; Lasker GF; McDermott MW; Kalkanis SN; Olson JJ
    Neurosurgery; 2019 Mar; 84(3):E159-E162. PubMed ID: 30629211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice patterns for postoperative radiation therapy in patients with metastases to the long bones: a survey of the Japanese Radiation Oncology Study Group.
    Kubota H; Nakamura N; Shikama N; Tonari A; Wada H; Harada H; Nagakura H; Heianna J; Ito K; Nozaki M; Tago M; Fushiki M; Uchida N; Araki N; Sekii S; Kosugi T; Takahashi T; Kawamoto T; Saito T; Yamada K
    J Radiat Res; 2021 Mar; 62(2):356-363. PubMed ID: 33454759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic Body Radiation Therapy for Nonspine Bone Metastases: International Practice Patterns to Guide Treatment Planning.
    Nguyen TK; Sahgal A; Dagan R; Eppinga W; Guckenberger M; Kim JH; Lo SS; Redmond KJ; Siva S; Stish BJ; Tseng CL
    Pract Radiat Oncol; 2020; 10(6):e452-e460. PubMed ID: 32171852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality.
    Ko EC; Formenti SC
    Int J Radiat Biol; 2019 Jul; 95(7):936-939. PubMed ID: 31120369
    [No Abstract]   [Full Text] [Related]  

  • 20. Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer.
    Mahadevan A; Moningi S; Grimm J; Li XA; Forster KM; Palta M; Prior P; Goodman KA; Narang A; Heron DE; Lo SS; Urbanic J; Herman JM
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):206-216. PubMed ID: 33358561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.